Viewing Study NCT04377659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2026-01-30 @ 11:15 PM
Study NCT ID: NCT04377659
Status: TERMINATED
Last Update Posted: 2025-05-28
First Post: 2020-05-04
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVD-19 View
None Tocilizumab View
None Respiratory infection View
None 20-185 View
None Memorial Sloan Kettering Cancer Center View